Skip to content
mapperlab
← Dashboard
Stock

NVAX

NOVAVAX, INC.
Latest close $8.937 of 27 marquee funds currently hold2 CUSIPs mapped
Current holders
7
27 funds tracked
Ever held
9
Current + past
New this quarter
2
Exited this quarter
0

Marquee-fund ownership over time

Nov 12, 2021Aug 9, 2024Aug 14, 2025May 15, 2026
Now
9

This quarter's activity

New positions opened

Positions exited

None.

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Coatue Management re-entered$48$8.93-81%
Renaissance Technologies re-entered$12$8.93-23%
Citadel Advisors$12$8.93-27%
D.E. Shaw$12$8.93-27%
Millennium Management$12$8.93-27%
Point72 Asset Management re-entered$0.00$8.93—
AQR Capital Management$7.22$8.93+24%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Two Sigma Investments 2× in & out—+0%
Bridgewater Associates→ $22-87%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at NOVAVAX INC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
2
Filings · last 90d
18
Total on file
484
Recent SEC buffer
Most recent
Apr 28, 2026

30d / 90d windows measured from Apr 28, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 484 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · NOVAVAX, INC.

Annual figures sourced directly from NOVAVAX, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$1.12B
FY2025+65% YoY
Net income
$440.3M
FY2025+335% YoY
EPS (diluted)
$2.58
FY2025+310% YoY
Free cash flow(?)
-$244.64M
FY2025-180% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for NOVAVAX INC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Coatue ManagementQ2 2026open$9.06$10+12%
Renaissance TechnologiesQ2 2026open$9.35$8.93-4%
Point72 Asset ManagementQ4 2025open$6.97$8.93+28%
Coatue ManagementQ2 2025Q1 2026$6.29$8.65+38%
Two Sigma InvestmentsQ1 2025Q3 2025$0.00—+0%
AQR Capital ManagementQ4 2024open$7.22$8.93+24%
Citadel AdvisorsQ3 2024open$12$8.93-27%
Two Sigma InvestmentsQ3 2024open$12$8.93-27%
D.E. ShawQ3 2024open$12$8.93-27%
Millennium ManagementQ3 2024open$12$8.93-27%
Point72 Asset ManagementQ3 2024open$0.00—+0%
Renaissance TechnologiesQ3 2024Q1 2026$12$8.42-27%
Coatue ManagementQ1 2024Q1 2025$4.10$8.19+100%
Coatue ManagementQ2 2022Q4 2023$48$6.24-87%
Bridgewater AssociatesQ4 2021Q4 2022$170$22-87%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.